Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Support us
Support us
  • Home
  • Marc van de Wetering

Marc van de Wetering

Senior Scientist

Development of organoid technology for pediatric solid tumors.

Publications

103 publications in total

  • Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities

    • mei 2023
    • Irene, Paassen, et al
    • Oncogene

  • Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes

    • aug. 2022
    • Michael T, Meister, et al
    • EMBO molecular medicine

  • Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors

    • apr. 2022
    • Bram, Herpers, et al
    • Nature Cancer

  • Author Correction

    • mrt. 2022
    • , et al
    • Nature Communications

  • EWSR1-WT1 Target Genes and Therapeutic Options Identified in a Novel DSRCT In Vitro Model

    • dec. 2021
    • Margit, Bleijs, et al
    • Cancers 2021, 13(23), 6072
View all publications